FASN and colorectal cancer: For example, the FASN inhibitor TVB-3664 has shown significant anti-cancer activity in colorectal cancer models, an effect correlated with the upregulation of CD36, suggesting a compensatory mechanism involving increased fatty acid uptake [36].